Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Howell

Showing results (161-170 of 743) with videos related to

Pageof 75
Sort By:
Acta Medica Austriaca|January 1, 1989
Novel approaches to intraperitoneal drug deliveryS B Howell, S Kirmani, R Goel
European Journal of Cancer & Clinical Oncology|September 1, 1985
Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protectionM Markman, S Cleary, S B Howell
Blood|March 1, 1980
Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemiaS B Howell, R Taetle, J Mendelsohn
Journal of Cellular Physiology|June 1, 1994
Cisplatin sensitivity correlates with its ability to cause cell cycle arrest via a wee1 kinase-dependent pathway in Schizosaccharomyces pombeF Thiebaut, R Enns, S B Howell
Cancer Research|April 1, 1979
Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexateS B Howell, A Krishan, E Frei
Molecular Biology & Medicine|October 1, 1987
Evidence against ras activation in human ovarian carcinomasM Haas, J Isakov, S B Howell
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexateR Goel, R Sanga, S B Howell
Molecular Pharmacology|November 1, 1996
Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombeP Perego, G Jimenez, S B Howell
Cell Communication and Signaling : CCS|October 26, 2014
Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-cateninXiying Shang, Xinjian Lin, Stephen B Howell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Pharmacological basis for a novel therapeutic strategy based on the use of aquated cisplatinH Zheng, D Fink, S B Howell
Pageof 75

Showing results (161-170 of 743) with videos related to

Sort By:
Pageof 75
Acta Medica Austriaca|January 1, 1989
Novel approaches to intraperitoneal drug deliveryS B Howell, S Kirmani, R Goel
European Journal of Cancer & Clinical Oncology|September 1, 1985
Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protectionM Markman, S Cleary, S B Howell
Blood|March 1, 1980
Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemiaS B Howell, R Taetle, J Mendelsohn
Journal of Cellular Physiology|June 1, 1994
Cisplatin sensitivity correlates with its ability to cause cell cycle arrest via a wee1 kinase-dependent pathway in Schizosaccharomyces pombeF Thiebaut, R Enns, S B Howell
Cancer Research|April 1, 1979
Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexateS B Howell, A Krishan, E Frei
Molecular Biology & Medicine|October 1, 1987
Evidence against ras activation in human ovarian carcinomasM Haas, J Isakov, S B Howell
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexateR Goel, R Sanga, S B Howell
Molecular Pharmacology|November 1, 1996
Isolation and characterization of a cisplatin-resistant strain of Schizosaccharomyces pombeP Perego, G Jimenez, S B Howell
Cell Communication and Signaling : CCS|October 26, 2014
Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-cateninXiying Shang, Xinjian Lin, Stephen B Howell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Pharmacological basis for a novel therapeutic strategy based on the use of aquated cisplatinH Zheng, D Fink, S B Howell
Pageof 75